SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-05-002500
Filing Date
2005-05-20
Accepted
2005-05-20 15:50:51
Documents
4
Period of Report
2005-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_4908.htm 8-K 13540
2 EX-3.1 exhibit1.htm EX-3.1 4296
3 EX-10.1 exhibit2.htm EX-10.1 68825
4 EX-10.2 exhibit3.htm EX-10.2 50101
  Complete submission text file 0001299933-05-002500.txt   138405
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 05848269
SIC: 2836 Biological Products, (No Diagnostic Substances)